Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies

BACKGROUND: Metformin is one of the most common drugs for type 2 diabetes mellitus (T2DM) treatment. In addition, metformin intends to have a positive effect on the prognosis of several cancers. However, the therapeutic effect of metformin on gastric cancer (GC) remains controversial. This study exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingna, Huang, Jianing, Huang, Tongmin, Yao, Jie, Zhang, Yeyuan, Chen, Meiling, Shentu, Haojie, Lou, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008112/
https://www.ncbi.nlm.nih.gov/pubmed/36915376
http://dx.doi.org/10.1155/2023/5892731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008112/
https://www.ncbi.nlm.nih.gov/pubmed/36915376
http://dx.doi.org/10.1155/2023/5892731

Ejemplares similares